Target- |
MechanismHepatitis C virus replication inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with MIP-11 LLC
0 Patents (Medical) associated with MIP-11 LLC
100 Deals associated with MIP-11 LLC
100 Translational Medicine associated with MIP-11 LLC